MENU

Supply Chain Intelligence about:

Aurobindo Pharma USA Inc.

Company profile   United States

See Aurobindo Pharma USA Inc.'s products and suppliers

Thousands of companies like you use Panjiva to research suppliers and competitors.

Easy access to trade data

4,724 US import shipments
US

U.S. Customs records organized by company

4,724 U.S. shipments available for Aurobindo Pharma USA Inc., updated weekly since 2007
Date Supplier Customer Details 43 more fields
2023-05-09 Aurobindo Pharma Ltd.
Aurobindo Pharma USA Inc.
XXXXX XX XXXXXXXX XXX XXXXX XXX XXXXXXXX XX XXXX XXXXXXXXX XXXXXXXXXX XXXXXXX X XX X XXXXXXXXXX XXXXXXX XXX X XXX XXXXX XXXX XX X XXXX XXX XXXXX XXX XXXXXXXXXXXX XXXXXXX X XX XXXXXXXXXXXXX XXXXXXX XXX X XXX XXXX XXXX XX X XXXX XXX XXXXXXXX XXXXXXXXXX XXXXXX XX XXXXX XXXXXXXXXXX XXXXXXXX XXX XXX XXX XXXXXX XXXX XX X XXXX XXX XXXXXXXX XXXXXXXX XXX XXXXXXX XXXXX XXXXXXXXXXX X XXXXXXX XXX XXX XXX XXXX
Bill of lading
2023-05-03 Aurobindo Pharma Ltd.
Aurobindo Pharma USA Inc.
XXXXX XX XXXXXXXX XXX XXXXX XXX XXXXXXXX XX XXXX XXXXXXXXX XXXXXXXXXXX XXXXXXX XX XX XXXXXXXXXXXX XXXXXXX XXXXX X XXX XXXX XX X XXXX XXX XXXXXXX X XXXXXXXX XXXXXXX XXXX XX XXXXXXX XXXXXXXX XXXXXXX XXX X X XXX XXXXX XXXX XX X XXXX XXX XXXXXXXX XXXXXXXX XXXXXXX XXXX XXXXXXXXX XXXXXXXX XXXX XXX XXX XX XXX XXXXX XXXX XX X XXXX XXX XXXXXXXX XXX XXX XXXXXXXXXX XXX XXX XXX XXXX XXXXXXXXXX XXX XXXXXXXXXXX
Bill of lading
2023-05-03 Apl Healthcare
Aurobindo Pharma USA Inc.
XXXXX XX XXXXXXXX XXX XXXXX XXX XXXXXXXX XX XXXX XXXXXXXXX XXXXXXXXXXX XXXXXXX XXXX XXXXXXXXXXXX XXXXXXX XXX XX XX X XX X XXXX XXXXXXXXXX XXXX XXXX XX X XXXX XXX XXXXXXXX XXXXXXXXX XXXXXXX XXX XXX X XXXXXXXXX XXXXXXX XXX XXX X XX XXX XXXX XXXXXXXXXX XXXXX XXX X XX X XXXX XXX XXXXXXXX XX XXXXXXX XXXXXXX XXX XXX XXXXX XXXXX XXXXXXX XXX XXX X XXXXX XXXX XXXXXXXXXX XXXXX XXXX XX X XXXX XXX XXXXXXXXXXX
Bill of lading
Shipment data shows what products a company is trading and more. Learn more

Explore trading relationships hidden in supply chain data

Contact information for Aurobindo Pharma USA Inc.

 
Address
279 PRINCETON-HIGHTSTOWN RD EAST WINDSOR NJ 0 EAST WINDSOR NJ 08520 US
 
 

Sample Bill of Lading

13,645 shipment records available

Date
2023-05-09
Shipper Name
Aurobindo Pharma Ltd.
Shipper Address
CORP.OFF: GALAXY FLOORS: 22-24 PLOT NO.1 SURVEY NO.83/1 RAIDURG PANMAKTHA HYDERABAD TERANGAREDDY-500081 PAN NO
Consignee Name
Aurobindo Pharma Usa., Inc,
Consignee Address
2400 ROUTE 130 NORTH DAYTON NJ 08810 UNITED STATES
Weight
20339
Weight Unit
LB
Weight in KG
9225.615
Quantity
38
Quantity Unit
PKG
Measure
62
Measure Unit
CM
Shipment Origin
India
Details
9,225.615 kg
From port: Jawaharlal Nehru, India
To port: New York/Newark Area, Newark, New Jersey
Place of Receipt
Jawaharlal Nehru
Foreign Port of Lading
Jawaharlal Nehru, India
U.S. Port of Unlading
New York/Newark Area, Newark, New Jersey
U.S. Destination Port
New York/Newark Area, Newark, New Jersey
Commodity
XXXXX XX XXXXXXXX XXX XXXXX XXX XXXXXXXX XX XXXX XXXXXXXXX XXXXXXXXXX XXXXXXX X XX X XXXXXXXXXX XXXXXXX XXX X XXX XXXXX XXXX XX X XXXX XXX XXXXX XXX XXXXXXXXXXXX XXXXXXX X XX XXXXXXXXXXXXX XXXXXXX XXX X XXX XXXX XXXX XX X XXXX XXX XXXXXXXX XXXXXXXXXX XXXXXX XX XXXXX XXXXXXXXXXX XXXXXXXX XXX XXX XXX XXXXXX XXXX XX X XXXX XXX XXXXXXXX XXXXXXXX XXX XXXXXXX XXXXX XXXXXXXXXXX X XXXXXXX XXX XXX XXX XXXXX X XXX XX X XXXX XXX XXXXXXXX XXX XXX XXXXXXXXXX XXX XXX XXX XXXXXXXXXXXX XXX XXXXXXXXX XXXXXXXXXXXX XXX XXXXXXXXX XX X XXX XXXXXXX XXX XXX XXX XXXX XXX XXX XXXXX XXX XXX XXXXX XX X XXXXXX XXXXXXX XXXXX XXXX XXXXXXXXXXX XXXXXXXXXXX XXXXX XXXXXX XXXXXXXXXXX XXXXXXXXXXX XXXXXXXXXXXX XXXXXXXXXXX X XX XXXXX XXXXXXXX XXXXXXX XXX XXXXX XXXXXXXX XXXXXXX
Container
MNBU0525760
Carrier Name
MAERSK LINE
Vessel Name
MAERSK COLUMBUS
Voyage Number
314W
Bill of Lading Number
MAEU226438513
Lloyd's Code
9332987
HTS Codes
HTS 3004.90

Recent Panjiva Research about Aurobindo Pharma USA Inc.

20161216-anticonvulsants-total-1

Drug Misuse Rule Changes Visible in AC Trade Data

Yet, within the class, imports of gabapentin (generic Neurontin) dropped 18%. This may be linked to new reporting requirements relating to misuse of the drug as a painkiller. That change may have driven a switch to generic versions of GSK’s Lamotrigine and UCB’s Keppra which both reached recor... Read more →